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1. INTRODUCTION 
A key step in the biosynthesis of progesterone 
and of androgens is the production of A4-3-keto- 
steroids from A5-3/I-hydroxysteroids [ 11. This enzy- 
matic conversion is a two step process in which 
dehydrogenation is followed by isomerization 121. 
The first step is rate limiting, and the enzyme which 
mediates the dehydrogenation is A5-3&hydroxy- 
steroid dehydrogenase (EC 1.1.1.145); it can be 
found in extracts of Pseudomonas testosteroni [3] 
and is localized in the microsomes and mitochon- 
dria of all steroid synthesizing organs such as 
adrenal, ovary, placenta and testis [4]. 
and stored at - 20” C. The cyanoketone used was 2~ 
cyano- 4,4,17cu~trimethylandrost-5-en-17fi-ol-3-one. 
/3-Nicotinamide adenine dinucleotide was pur- 
chased from Sigma Chem. Co. (St Louis MO). All 
other chemicals were of analytical grade and were 
obtained from Sigma, Boehringer or Merck AG 
(Darmstadt). 
2.1. Enzyme extraction from rat testes 
The enzymes from mammalian and bacterial 
sources were reported to exhibit similar properties 
[5] and were found to be inhibited by estrogens, 
progestins, androgens and steroidal analogues 
[5,16]. Genital defects such as hypospadias in male 
infants were reported to be associated with the ad- 
ministration of progestins and estrogens to preg- 
nant women or female animals 191. Inhibition by 
these steroids of A5-3/3-hydroxysteroid dehydro- 
genase has been assumed to cause hypospadias 
[9,10,17]. 
Here, we have studied the effects of some proges- 
tins and estrogens on rat testis A5-3/%hydroxy- 
steroid dehydrogenase activity using both de- 
hydroepiandrosterone and pregnenolone as sub- 
strate. 
2. MATERIALS AND METHODS 
All steroids used in this study were obtained from 
Schering AG (Berlin) and were dissolved in ethanol 
Testes of adult male rats of the Sprague-Dawley 
strain (Himberg; Oncins, specific-pathogen free, 
200-250 g body wt were obtained from For- 
schungsinstitut fur Versuchstierzucht, University of 
Vienna. The animals were used 2 weeks after ship- 
ment. The rats were housed in a temperature-con- 
trolled room lit for 12 h/day and unrestricted access 
was provided to food and water. The rats were 
killed by decapitation and the testes were dissected, 
decapsulated and rinsed with ice-cold buffer 1 (50 
mM phosphate buffer, 0.25 M sucrose, 7 mM di- 
thiothreitol, 0.5 mM EDTA, pH 7.4). All further 
procedures were done at 0-4°C. Tissue (1 g/ml 
buffer 1) was homogenized by 10 strokes at 1000 
rev./min in a glass-Teflon Potter Elvehjem-type 
homogenizer. The homogenate was centrifuged at 
800 x g for 10 min. The crude homogenate was 
centrifuged at 10 000 X g for 20 min and the 
supernatant was spun at 100 000 x g for 1 h to ob- 
tain the microsomal pellet. The microsomes were 
washed with buffer 1 and recentrifuged at 100 000 
x g for 1 h. The pellet was resuspended by homo- 
genizing it in 1 ml buffer l/pair of testes to obtain 
5-10 mg protein/ml. The suspension was stored at 
-20°C until used for enzyme assays. 
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2.2. Enzyme assay 
The enzyme preparation (300 ~1) containing 
1.5-4 mg protein was preincubated at 37°C with 
750 ~1 buffer (0.2 M pyro 
4 
hosphate, pH 8.9) 200 ~1 
NAD solution (5 X 10 - M, pH 7) and 1550 ~1 
water. The reaction was started with dehydro- 
epiandrosterone or pregnenolone as substrate dis- 
solved in ethanol. The total volume of ethanol did 
not exceed 100 ~1, and the blank contained all 
components except for the substrate. For the deter- 
minations of inhibition constants the reaction 
mixture was preincubated with the steroid to be 
tested prior to the addition of substrate. Absorbance 
was recorded at 340 nm by a Beckman spectro- 
photometer model DU-8 kinetic analysis system 
(Beckman Instr., Irvine CA) at 37°C. AAlmin was 
registered 3 times through 3 min intervals and cal- 
culated as means of 3 such determinations. 
2.3. Other techniques 
Michaelis constants were determined by linear 
regression analysis of Lineweaver Burk [ 181 data 
and inhibition constants were calculated from 
Dixon-plot [ 191 data by linear regression on a Dee 
Data System 34/l 1 (Digital Equipment Corp., 
Maynard, MA). Protein measurements were done 
as in [20] using bovine serum albumin as standard. 
3. RESULTS AND DISCUSSION 
Whether or not a single A5-3P-hydroxysteroid 
dehydrogenase metabolizes various substrates such 
Table 1 
Determination of Michaelis constants of d5-3fi-hydroxy- 
steroid dehydrogenase from rat testes microsomes for 
various substrates 
Steroid 
Dehydroepiandrosterone 
Pregnenolone 
Dehydroepiandrosterone plus 
K,(M x 10-6) 
5.1 
2.3 
pregnenolone (equimolar) 3.4 
Rat testes microsomal enzyme preparation (300 ml) con- 
taining 1.5-4 mg protein was incubated with various 
concentrations of different substrates in the presence of 
5 x 10 -3 M NAD. Data are given as means of 3 different 
experiments 
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as dehydroepiandrosterone and pregnenolone has 
been studied in many laboratories. The present in- 
vestigation was done to delineate possible differ- 
ences between C- 19 and C-2 1 testicular deydrogen- 
ases and to investigate whether A5-3fi-hydroxy- 
steroid dehydrogenase is inhibited by estrogens and 
progestins. Data on the Michaelis constants (table 
1) add further evidence to the suggestion [21-241 
that A5-3P-hydroxysteroid dehydrogenases medi- 
ating the dehydrogenation of C- 19 and C-2 1 steroids 
in the testes are identical: equimolar mixtures of 
dehydroepiandrosterone and pregnenolone did not 
give additive rates, but maximal velocities interme- 
diate between those of the separate substrates. How- 
ever, multiple A5-3fl-hydroxysteroid dehydrogen- 
ases in bovine ovarian microsomes were proposed 
in [21]. Experiments on hydride-ion transfer from 
the 2 substrates to NAD+ suggested the presence of 
1 enzyme which metabolized only dehydroepi- 
androsterone and 1 enzyme which used both pregnen- 
olone and dehydroepiandrosterone [2 11. Evidence 
for multiple dehydrogenases may raise many im- 
Table 2 
Determination of apparent inhibition constants (K,) of 
A5-3P-hydroxysteroid dehydrogenase for various steroids 
using dehydroepiandrosterone (5.78 X 10 -6 M or 
46.24 x 10e6 M) or pregnenolone (5.27 x 10e6 M or 
42.12 x 10e6 M) as substrate 
Steroid K, (M x 10-6) 
Dehydroepi- Pregnen- 
androsterone olone 
Norethisterone 
Norethisterone acetate 
Diethylstilbestrol 
Progesterone 
Cyproterone acetate 
Cyanoketone 
Androstenedione 
17/3-Estradiol 
17a-OH-Progesterone 
n.i. 
150 
63 
n.i. 
47 
0.03 
30 
n.i. 
n.d. 
n.i. 
175 
29” 
n.i. 
ni. 
0.03a 
40 
n.d. 
n.i. 
a non-competitive 
n.i., not inhibitory; n.d., not determined 
Steroids were preincubated with 300 ~1 enzyme prepara- 
tion containing 1.5-4 mg protein in the presence of 
5 x 10 -3 M NAD. Data are given as means of two dif- 
ferent experiments 
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portant questions concerning the distribution of the 
enzymes in different cell types and the possibility of 
different effects of trophic hormones. These data 
suggest a single enzyme but examination of stereo- 
specificity of hydride transfer may yield a more 
definitive answer to the question. 
Of major interest is the observation that nor- 
ethisterone does not inhibit testicular A5-3p- 
hydroxysteroid dehydrogenase, when dehydroepi- 
androsterone or pregnenolone is used as substrate 
(table 2). Inhibition by progestins of this enzyme 
was proposed for the development of hypospadias 
in male infants born from females who were treated 
with norethisterone or other synthetic progestagens 
1171. This assumption was made on grounds of 
results of experiments in which male fetuses of 
pregnant rats treated with these steroids were found 
to develop hypospadias. The effect of progestins on 
sexual organogenesis was thought to be analogous 
to that observed in infants born with a severe form 
of congenital adrenal hyperplasia due to genetic 
deficiency of A5-3/?-hydroxysteroid dehydrogenase. 
In addition, injection of cyanoketone into preg- 
nant rats was found to inhibit adrenal and testicular 
A5-3fi-hydroxysteroid dehydrogenase as noted by 
histochemical determinations and was registered 
to produce hypospadias [lo]. But a recent review 
[25] concludes that adverse effects of synthetic pro- 
gestins on the fetus had been shown in some, but not 
all, of the reports, and that any positive effects reg- 
istered were small. Inhibition by norethisterone of 
testicular of A5-3/I-hydroxysteroid dehydrogenase 
activity could not be detected by the present assay 
system when dehydroepiandrosterone or pregnen- 
olone were used as substrates (table 2). In addi- 
tion, no great differences were noted between the 
7576- 
6818- 
6061- 
5303- 
4546 - 
3788- 
3030- 
2273- 
I/V 
I I I I I I 
13.3 
t 
26.6 
MxlCP 
39.9 53.2 66.5 79.8 
Fig. I. Dixon plot of inhibition by androstenedione of testicular A5-3jShydroxysteroid dehydrogenase: (o) 5.2 x 10P6 M 
pregnenolone; ( .cJ 42.18 X 10 -6 M pregnenolone: V = velocity in mU . min -I . mg protein -I. 
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4802 - 
4268- 
3135 - 
3201- 
2668 -
2134- 
1601 -
1067 - 
534 - 
-?/ 0 
0’ 
1 1 I I , I 1 W- MxlO-" 
17.8 35.6 53.4 71.2 89.0 106.8 124.6 142.5 
Fig.2. Dixon plot of inhibition by diethylstilbestrol of rat testis A5-3/I-hydroxysteroid ehydrogenase, pregnenolone: 
(3) = 5.2 x 10 -f~ M; (A) = 42.18 x 10 -6 M; V = velocity in mu. min -t . mg protein -I. 
apparent inhibition constants registered for the de- 
hydroepiandrosterone and prenenolone system, re- 
spectively. The only apparent difference was found 
for cyproterone acetate which was slightly inhibi- 
tory when dehydroepiandrosterone was used as 
substrate, but no inhibition was observed for the 
pregnenolone system (table 2). A residual affinity of 
norethisterone acetate for A5-3-/I-hydroxysteroid 
dehydrogenase was observed. Since the affinity of 
norethisterone acetate is only 1% of the Km and 
since the acetate is split very rapidly in vivo, no 
effect of the progestin on the enzyme system is ex- 
pected to take place in vivo. In addition, androster- 
onedione was observed to competitively inhibit the 
enzyme system (fig.1). Accumulation of this inter- 
mediate could, therefore, act on both the dehydro- 
epiandrosterone as well as pregnenolone system by 
feedback inhibition. Furthermore, a weak affinity 
of diethylstilbestrol for the enzyme was registered 
(tig.2) indicating that estrogenic substances may 
also inhibit testicular A5-3P-hydroxysteroid de- 
hydrogenase activity when pregnenolone is used as 
substrate. However, no inhibition was found for 
17/3-estradiol when dehydroepiandrosterone was 
used (table 2). 
Both diethylstilbestrol (fig.2) and cyanoketone 
(lig.3) inhibited the enzyme in a non-competitive 
manner when the pregnenolone system was studied, 
whereas competitive inhibition was registered in the 
dehydroepiandrosterone assay system (table 2). 
These data and the differences found for cyproter- 
one acetate may support the notion that more than 
one enzyme system is responsible for the conver- 
sion of C-19 and C-21 steroids. Non-competitive 
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17242- 
15517- 
13793- 
12069- 
10345- 
3621 - 
6897 - 
.5172- 
3448 - 
1724 - 
Mx1U6 
Fig.3. Analysis of inhibition by cyanoketone of testicular A5-3/3-hydroxysteroid dehydrogenase by Dixon plot. 
Pregnenolone: (o) 5.2 x 10 -6 M; (A) 42.18 X 10 -6 M; V = velocity in mu. mini . mg -I. 
inhibition by cyanoketone of Pseudomonas testos- 
teroni A5-3/%hydroxysteroid dehydrogenase was 
reported in 151. 
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